What is Amyloid Peptide?
Amyloids peptide is a soluble peptide of 40 or 42 amino acids. It is filamentous protein deposits, made up of long, insoluble ordered fibres, are glycoproteins deposited extracellularly in tissues in amyloidosis. It is composed of aggregated peptide beta-sheets formed from parallel or anti-parallel alignments of peptide beta-strands. Its size ranges from nanometres to microns. Amyloids peptide are used mostly for research purpose. Of which, Alzheimer's disease, Diabetes mellitus type 2, Rheumatoid arthritis are major research areas.
Global Amyloid Peptides Market Outlook
Amyloid peptide-based drugs have emerged as a major class of therapeutics, and as a result of extensive efforts of researchers and pharmaceutical companies. During the last decade has witnessed impressing scientific interest in their therapeutic uses due to the increasing incidence of Alzheimer's. Amyloid peptides have gained popularity as one of the most investigated molecules in Alzheimer Decease research projects and efforts are being made globally to develop peptide-based compounds for the initial diagnosis and treatment of Alzheimer Decease.
From the past few decades, Alzheimer Decease and its related risk factors have become major healthcare concerns in many developed countries. In addition, it has been reported, Alzheimer Decease as the fifth-leading cause of death among the population aged above 65 years. According to Alzheimer's Association, 2017, incidence exceeds five million cases per year in the United States and World Health Organization (WHO) predicted that the prevalence of Alzheimer's Decease worldwide will multiply to reach approximately 114 million by 2050. Recently, several research groups, found that Amyloid peptide vaccination chronically lower Alzheimer's Decease levels and reduces Alzheimer's Decease -associated pathology. Also, amyloid peptides have been implicated in cancer development, experimental evidence shows that amyloid peptides are capable of inhibiting tumour cell growth, while the evidence from clinical trials does not favour the role for amyloid peptides in the suppression of cancer, but it is possible to play an indirect role by intercepting oncogenic viruses.
Global Amyloid Peptides Market Competitive Landscape
The "Global Amyloid Peptides Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as AmideBio, Cambridge Research Biochemicals, BioLegend, AnaSpec, Inc, rPeptide, Genscript, Bio-Synthesis, NovoPro Inc. and Bachem. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL AMYLOID PEPTIDES MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL AMYLOID PEPTIDES MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL AMYLOID PEPTIDES MARKET, BY TYPE
5.1. Overview
5.2. Beta-Amyloid Mouse
5.3. Beta-Amyloid Rat
5.4. Beta-Amyloid Human
6. GLOBAL AMYLOID PEPTIDES MARKET, BY APPLICATION
6.1. Overview
6.2. Alzheimer's Disease Research
6.3. Cancer Research
6.4. Lewy Body Dementia Research
6.5. Inclusion Body Myositis Research
6.6. Cerebral Amyloid Angiopathy Research
6.7. Others
7. GLOBAL AMYLOID PEPTIDES MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
8. GLOBAL AMYLOID PEPTIDES MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. 3M
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Acelity LP Inc.
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. ConvaTec Group Plc,
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Mölnlycke Health Care AB.
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Smith & Nephew Plc
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Derma Sciences.
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Stratpharma.
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. BMG Pharma
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments
9.9. Laboratorios LETI
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments
9.10. Alliqua BioMedical.
9.10.1. Overview
9.10.2. Financial Performance
9.10.3. Product Outlook
9.10.4. Key Developments
10. Appendix
10.1. Related Reports
The global Recombinant Peptides market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Peptides Biosimilars market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
Overview of the Global Farm Animal Disease Control Peptides Market:
The report discusses everything a marketer requires before investing in the global Farm Animal Disease Control Peptides Market during the forecast ...
The global Endocrine Peptides Test market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...
The global Labeled Peptides market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...
The global Amyloid Oligomer market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...
The global Anti-Inflammatory Peptides market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Muscular Amino Acid and Peptides and Nucleosides for Injection market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 imp...
The global Serum Amyloid A Test Kit market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
Overview of the Global Pharmaceutical Peptides Services Market:
The report discusses everything a marketer requires before investing in the global Pharmaceutical Peptides Services Market during the forecast period 2...